Similar Articles
2581 Transarterial embolization of metastatic mediastinal hepatocellular carcinoma
2582 Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases
2583 Is the American Association for the Study of Liver Diseases recommendation for hepatocellular carcinoma screening a cul-de-sac?
2584 MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults
2585 High-intensity focused ultrasound ablation: An effective bridging therapy for hepatocellular carcinoma patients
2586 Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes
2587 Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh
2588 Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma
2589 Extremely high prevalence of Helicobacter pylori infection in Bhutan
2590 Mycotoxins are conventional and novel risk biomarkers for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA